Skip to main content

Good evening, here are the COVID-19 updates you need to know tonight.

Top headlines:

  1. Health Canada says it will decide whether to authorize a COVID-19 vaccine for kids “in the next one to two weeks.” The Pfizer-BioNtech vaccine for children aged 5-11 was authorized for use in the United States last week.
  2. Doctors say they’re concerned about lack of access to COVID-19 treatments that can prevent hospitalizations. Two new antiviral pills that may reduce the number of people who become severely ill with COVID-19 have risen in popularity in recent weeks, though they’re not yet approved by Health Canada. A handful of treatments called monoclonal antibodies have been approved, but the treatment is not widely available.
  3. Ontario’s COVID-19 science and modelling advisory tables released new projections today showing that ICU numbers are stable, though likely to rise, and that those with lower incomes, essential workers, and minority groups are at highest risk of COVID-19-related mortality.

In the past seven days, 17,661 cases were reported, up 15 per cent from the previous seven days. There were 177 deaths announced, down two per cent over the same period. At least 1,670 people are being treated in hospitals.

Canada’s inoculation rate is 15th among countries with a population of one million or more people.

Open this photo in gallery:

The Globe and Mail

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopening


Photo of the day

Open this photo in gallery:

Elsa Estrada, 6, smiles at her mother as pharmacist Sylvia Uong applies an alcohol swab to her arm before administering the Pfizer COVID-19 vaccine at a pediatric vaccine clinic for children ages 5 to 11 set up at Willard Intermediate School in Santa Ana, Calif. Tuesday, Nov. 9, 2021.Jae C. Hong/The Associated Press


Coronavirus in Canada


More than 80 per cent of Canadians say all MPs should be vaccinated against COVID-19, a new poll suggests.

  • The survey, conducted by Nanos Research for The Globe and Mail, found that 75.2 per cent of respondents said they “agree” and eight per cent said they “somewhat agree” with the statement: “All members of Parliament should be vaccinated for COVID-19.”
  • The issue has become a point of debate in light of a new House of Commons policy that will bar unvaccinated MPs from entering Parliament when sittings resume on Nov. 22.

The Decibel podcast: Three Canadian researchers on what we learned when the world went quiet during the COVID-19 lockdowns.


Coronavirus around the world

  • Europe has become the epicentre of the pandemic again, prompting some governments to consider reimposing unpopular lockdowns in the run-up to Christmas. The continent accounts for more than half of the average seven-day infections globally and about half of latest deaths, according to a Reuters tally.
  • Japan’s economic stimulus package will require fiscal spending worth 40 trillion yen ($440-billion) to spur the country’s economy, which is reeling from the coronavirus.

Coronavirus and business


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? E-mail us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe